[Clinical experience with clarithromycin in the pediatric field].
Clarithromycin (TE-031, A-56268) was orally administered to 20 children with the following acute bacterial infections; 1 case of acute pharyngitis, 3 cases of acute tonsillitis, 11 cases of acute bronchitis, 1 case of exacerbation of chronic bronchitis, 1 case of acute bronchopneumonia, 2 cases of Mycoplasma pneumonia and 1 case of impetigo. Clinical effectiveness was obtained in 15 out of the 20 cases (75.0%). No clinical side effects and laboratory abnormalities were observed. The above results suggest that TE-031 is a useful antibiotics for treating pediatric patients with various bacterial infections.
Tayama
M
M
Department of Pediatrics, School of Medicine, Tokushima University.
Ichioka
T
T
Hosoda
T
T
Miyao
M
M
D000284:Administration, Oral; D000293:Adolescent; D000367:Age Factors; D002648:Child; D002675:Child, Preschool; D017291:Clarithromycin; D004304:Dosage Forms; D004341:Drug Evaluation; D004917:Erythromycin / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007169:Impetigo / Q000188:drug therapy / Q000382:microbiology; D007223:Infant; D008297:Male; D012141:Respiratory Tract Infections / Q000188:drug therapy* / Q000382:microbiology
D004304:Dosage Forms; D004917:Erythromycin; D017291:Clarithromycin